Silo Pharma Inc. (SILO)
1.07
0.04 (3.88%)
At close: Apr 17, 2025, 3:56 PM
1.10
2.34%
After-hours: Apr 17, 2025, 07:44 PM EDT
3.88% (1D)
| Bid | 0.95 |
| Market Cap | 4.82M |
| Revenue (ttm) | 72.1K |
| Net Income (ttm) | -4.39M |
| EPS (ttm) | -1.19 |
| PE Ratio (ttm) | -0.9 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.1 |
| Volume | 13,625 |
| Avg. Volume (20D) | 162,811 |
| Open | 1.03 |
| Previous Close | 1.03 |
| Day's Range | 1.03 - 1.09 |
| 52-Week Range | 0.77 - 4.50 |
| Beta | 1.58 |
About SILO
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment ...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 8, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol SILO
Website https://silopharma.com
3 months ago
+56.88%
Silo Pharma shares are trading higher after the co...
Unlock content with
Pro Subscription
4 months ago
Silo Pharma shares are trading higher after the company announced a collaboration agreement with Kymanox for the specialized design and development of a subcutaneous insertion device for SP-26, a ketamine-loaded implant therapeutic targeting fibromyalgia and chronic pain.
2 months ago · businesswire.com
LIBERTY LATIN AMERICA'S C&W CREDIT SILO PRICES NEW $1.5 BILLION TERM LOAN DUE 2032DENVER, Colorado--(BUSINESS WIRE)--Liberty Latin America's (“LLA” or the “Company”) largest credit silo, Cable & Wireless (“C&W”), priced a new $1.5 billion term loan at the end of January 2025. This ...